Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul;15(4):968-969.
doi: 10.1177/1932296821997403. Epub 2021 Mar 11.

Applying Real-World Data to Inform Continuous Glucose Monitoring Use in Clinical Practice

Yaguang Zheng  1 , Linda M Siminerio  2   3 , Jodi Krall  3   4 , Bonnie B Anton  5 , Jacob C Hodges  5 , Lori Bednarz  3 , Dan Li  6 , Jason M Ng  2
Affiliations

Applying Real-World Data to Inform Continuous Glucose Monitoring Use in Clinical Practice

Yaguang Zheng et al. J Diabetes Sci Technol. 2021 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
HbA1C levels before and after use of continuous glucose monitoring.
See this image and copyright information in PMC

References

    1. Beck RW, Riddlesworth T, Ruedy K, et al.. Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial. JAMA. 2017;317:371-378. - PubMed
    1. Lind M, Polonsky W, Hirsch IB, et al.. Continuous glucose monitoring vs conventional therapy for glycemic control in adults with type 1 diabetes treated with multiple daily insulin injections: the GOLD randomized clinical trial. JAMA 2017;317:379-387. - PubMed
    1. Heinemann L, Freckmann G, Ehrmann D, et al.. Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial. Lancet. 2018;391:1367-1377. - PubMed
    1. U.S. Food and Drug Administration. Use of real-world evidence to support regulatory decision-making for medical devices. 2017. https://www.fda.gov/media/99447/download
    1. Sherman RE, Anderson SA, Dal Pan GJ, et al.. Real-world evidence - what is it and what can it tell us? N Engl J Med. 2016;375:2293-2297. - PubMed

Publication types